NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

Mary B. Daly(Fox Chase Cancer Center), Susan Darlow(National Comprehensive Cancer Network), Judy E. Garber(Dana-Farber Cancer Institute), Gwen Reiser(University of California San Diego), Meagan Farmer(University of Alabama at Birmingham), Jennifer K. Litton(The University of Texas MD Anderson Cancer Center), Jeffrey N. Weitzel(Cancer Genetics (United States)), Tuya Pal(Vanderbilt University Medical Center), Michael P. Berry(St. Jude Children's Research Hospital), Kristen M. Shannon(Massachusetts General Hospital), Robert Pilarski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Wendy Kohlmann(University of Utah), Nicoleta Voian(Roswell Park Comprehensive Cancer Center), Allison W. Kurian(Stanford University), Sofía D. Merajver(University of Michigan), Myra Wick(WinnMed), Georgia L. Wiesner(The University of Western Australia), Saundra S. Buys(University of Utah), Lisa Madlensky(UC San Diego Health System), Elizabeth M. Swisher(University of Washington), Catherine Klein(University of Utah), Susan Friedman(Facing Our Risk of Cancer Empowered), Shaveta Vinayak(Roswell Park Comprehensive Cancer Center), Mary A. Dwyer(National Comprehensive Cancer Network), Noah D. Kauff(Cancer Institute (WIA)), Seema Khan(University of Colorado Cancer Center), Kenneth Offit(Memorial Sloan Kettering Cancer Center)
Journal of the National Comprehensive Cancer Network
December 31, 2016
Cited by 660


Related Papers